Histologic transformation of follicular lymphoma: pathologists’                    viewpoint

Akiko Miyagi Maeshima

doi:10.3960/jslrt.22046

journal article Jan 01, 2023

Histologic transformation of follicular lymphoma: pathologists’ viewpoint

Journal of Clinical and Experimental Hematopathology Vol. 63 No. 1 pp. 12-18 · Japanese Society for Lymphoreticular Tissue Research

View at Publisher Save 10.3960/jslrt.22046

Topics

No keywords indexed for this article. Browse by subject →

References

48

[1]

1 Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon, IARC. 2017.

[2]

2 Fischer T, Zing NPC, Chiattone CS, Federico M, Luminari S. Transformed follicular lymphoma. Ann Hematol. 2018; 97: 17-29. 10.1007/s00277-017-3151-2

[3]

3 Davies AJ, Rosenwald A, Wright G et al. Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms. Br J Haematol. 2007; 136: 286-293. 10.1111/j.1365-2141.2006.06439.x

[4]

4 Al-Tourah AJ, Gill KK, Chhanabhai M et al. Population-based analysis of incidence and outcome of transformed non-Hodgkin’s lymphoma. J Clin Oncol. 2008; 26: 5165-5169. 10.1200/jco.2008.16.0283

[5]

5 Maeshima AM, Omatsu M, Nomoto J et al. Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma: morphological, immunohistochemical, and FISH analyses. Cancer Sci. 2008; 99: 1760-1768. 10.1111/j.1349-7006.2008.00873.x

[6]

6 Sham RL, Phatak P, Carignan J, Janas J, Olson JP. Progression of follicular large cell lymphoma to Burkitt’s lymphoma. Cancer. 1989; 63: 700-702. 10.1002/1097-0142(19890215)63:4<700::aid-cncr2820630417>3.0.co;2-s

[7]

7 Yano T, Jaffe ES, Longo DL, Raffeld M. MYC rearrangements in histologically progressed follicular lymphomas. Blood. 1992; 80: 758-767. 10.1182/blood.v80.3.758.758

[8]

8 Mukhopadhyay S, Readling J, Cotter PD, Shrimpton AE, Sidhu JS. Transformation of follicular lymphoma to Burkitt-like lymphoma within a single lymph node. Hum Pathol. 2005; 36: 571-575. 10.1016/j.humpath.2005.01.004

[9]

9 Xu X, Zhang L, Wang Y et al. Double-hit and triple-hit lymphomas arising from follicular lymphoma following acquisition of MYC: report of two cases and literature review. Int J Clin Exp Pathol. 2013; 6: 788-794.

[10]

10 Martinez-Mera C, Herrero-Moyano M, López-Elzaurdia C, Loscertales J, Aragües M. Cutaneous involvement in a high-grade B-cell lymphoma with rearrangement of MYC, BCL2, and BCL6 transformed from follicular lymphoma. Am J Dermatopathol. 2019; 41: 80-82. 10.1097/dad.0000000000001076

[11]

11 Jaffe ES, Zarate-Osorno A, Medeiros LJ. The interrelationship of Hodgkin’s disease and non-Hodgkin’s lymphomas--lessons learned from composite and sequential malignancies. Semin Diagn Pathol. 1992; 9: 297-303.

[12]

12 LeBrun DP, Ngan BY, Weiss LM et al. The bcl-2 oncogene in Hodgkin’s disease arising in the setting of follicular non-Hodgkin’s lymphoma. Blood. 1994; 83: 223-230. 10.1182/blood.v83.1.223.bloodjournal831223

[13]

13 Bräuninger A, Hansmann ML, Strickler JG et al. Identification of common germinal-center B-cell precursors in two patients with both Hodgkin’s disease and non-Hodgkin’s lymphoma. N Engl J Med. 1999; 340: 1239-1247. 10.1056/nejm199904223401604

[14]

14 Marafioti T, Hummel M, Anagnostopoulos I et al. Classical Hodgkin’s disease and follicular lymphoma originating from the same germinal center B cell. J Clin Oncol. 1999; 17: 3804-3809. 10.1200/jco.1999.17.12.3804

[15]

15 Maeshima AM, Taniguchi H, Nomoto J et al. Clinicopathological features of classical Hodgkin lymphoma in patients ≥40 years old, with special reference to composite cases. Jpn J Clin Oncol. 2015; 45: 921-928. 10.1093/jjco/hyv101

[16]

16 de Jong D, Voetdijk BMH, Beverstock GC et al. Activation of the c-myc oncogene in a precursor-B-cell blast crisis of follicular lymphoma, presenting as composite lymphoma. N Engl J Med. 1988; 318: 1373-1378. 10.1056/nejm198805263182106

[17]

17 Gauwerky CE, Haluska FG, Tsujimoto Y, Nowell PC, Croce CM. Evolution of B-cell malignancy: pre-B-cell leukemia resulting from MYC activation in a B-cell neoplasm with a rearranged BCL2 gene. Proc Natl Acad Sci USA. 1988; 85: 8548-8552. 10.1073/pnas.85.22.8548

[18]

18 Young KH, Xie Q, Zhou G et al. Transformation of follicular lymphoma to precursor B-cell lymphoblastic lymphoma with c-myc gene rearrangement as a critical event. Am J Clin Pathol. 2008; 129: 157-166. 10.1309/nkk3fex2be5l7ekb

[19]

19 Geyer JT, Subramaniyam S, Jiang Y et al. Lymphoblastic transformation of follicular lymphoma: a clinicopathologic and molecular analysis of 7 patients. Hum Pathol. 2015; 46: 260-271. 10.1016/j.humpath.2014.10.021

[20]

20 Lau SK, Weiss LM, Zhang Y, Huang Q. Prolymphocytoid transformation of follicular lymphoma with coexpression of CD5 and CD10. Leuk Lymphoma. 2006; 47: 541-547. 10.1080/10520290500305310

[21]

21 Ouansafi I, He B, Fraser C et al. Transformation of follicular lymphoma to plasmablastic lymphoma with c-myc gene rearrangement. Am J Clin Pathol. 2010; 134: 972-981. 10.1309/ajcpwy1sgj9ieaor

[22]

22 Martinez D, Valera A, Perez NS et al. Plasmablastic transformation of low-grade B-cell lymphomas: report on 6 cases. Am J Surg Pathol. 2013; 37: 272-281. 10.1097/pas.0b013e31826cb1d1

[23]

23 Yamada T, Hara T, Goto N, Iwata H, Tsurumi H. Follicular lymphoma suggested to transform into EBV-negative plasmablastic lymphoma. Int J Hematol. 2019; 109: 723-730. 10.1007/s12185-019-02591-4

[24]

24 Maeshima AM, Taniguchi H, Ida H et al. Non-diffuse large B-cell lymphoma transformation from follicular lymphoma: a single-institution study of 19 cases. Hum Pathol. 2020; 102: 33-43. 10.1016/j.humpath.2020.06.001

[25]

25 Alsabeh R, Medeiros LJ, Glackin C, Weiss LM. Transformation of follicular lymphoma into CD30-large cell lymphoma with anaplastic cytologic features. Am J Surg Pathol. 1997; 21: 528-536. 10.1097/00000478-199705000-00004

[26]

26 Maeshima AM, Taniguchi H, Nomoto J et al. Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin’s lymphoma after rituximab therapy. Cancer Sci. 2009; 100: 54-61. 10.1111/j.1349-7006.2008.01005.x

[27]

27 Raess PW, Wang HW, Pack SD, Jaffe ES. CD30+ large B cell lymphoma with anaplastic features and complete loss of B cell marker expression arising from follicular lymphoma. Histopathology. 2019; 75: 602-605. 10.1111/his.13919

[28]

28 Feldman AL, Arber DA, Pittaluga S et al. Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone. Blood. 2008; 111: 5433-5439. 10.1182/blood-2007-11-124792

[29]

29 Brunner P, Rufle A, Dirnhofer S et al. Follicular lymphoma transformation into histiocytic sarcoma: indications for a common neoplastic progenitor. Leukemia. 2014; 28: 1937-1940. 10.1038/leu.2014.167

[30]

30 Alaggio R, Amador C, Anagnostopoulos I, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022; 36: 1720-1748. 10.1038/s41375-022-01620-2

[31]

31 Siebert R, Alaggio R, Dave SS. Transformations of indolent B-cell lymphomas. In: WHO Classification of Tumours Editorial Board. Haematolymphoid tumours. Lyon (France): International Agency for Research on Cancer. (WHO classification of tumours series, 5th ed.; vol. 11). https://publications.iarc.fr.

[32]

32 Leoncini L, Delsol G, Gascoyne RD et al. Aggressive B-cell lymphomas: a review based on the workshop of the XI Meeting of the European Association for Haematopathology. Histopathology. 2005; 46: 241-255. 10.1111/j.1365-2559.2005.02068.x

[33]

33 Maeshima AM, Taniguchi H, Toyoda K et al. Clinicopathological features of histological transformation from extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue to diffuse large B-cell lymphoma: an analysis of 467 patients. Br J Haematol. 2016; 174: 923-931. 10.1111/bjh.14153

[34]

34 Maeshima AM, Taniguchi H, Hori Y et al. Diagnostic utility and prognostic significance of the Ki‐67 labeling index in diffuse large B‐cell lymphoma transformed from follicular lymphoma: a study of 76 patients. Pathol Int. 2021; 71: 674-681. 10.1111/pin.13148

[35]

35 Broyde A, Boycov O, Strenov Y et al. Role and prognostic significance of the Ki-67 index in non-Hodgkin’s lymphoma. Am J Hematol. 2009; 84: 338-343. 10.1002/ajh.21406

[36]

36 Samols MA, Smith NE, Gerber JM et al. Software-automated counting of Ki-67 proliferation index correlates with pathologic grade and disease progression of follicular lymphomas. Am J Clin Pathol. 2013; 140: 579-587. 10.1309/ajcptma1f6lwytqv

[37]

37 Kawaguchi Y, Shiozawa E, Shimada S et al. Ki-67 expression of immunohistochemistry using computerized image analysis is a useful prognostic marker in follicular lymphomas. Int J Clin Exp Pathol. 2018; 11: 3366-3374.

[38]

38 Hans CP, Weisenburger DD, Greiner TC et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004; 103: 275-282. 10.1182/blood-2003-05-1545

[39]

39 Davies AJ, Rosenwald A, Wright G et al. Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms. Br J Haematol. 2007; 136: 286-293. 10.1111/j.1365-2141.2006.06439.x

[40]

40 Kridel R, Chan FC, Mottok A et al. Histological transformation and progression in follicular lymphoma: A clonal evolution study. PLoS Med. 2016; 13: e1002197. 10.1371/journal.pmed.1002197

[41]

41 Alvaro-Naranjo T, Jaén-Martínez J, Gumá-Padró J, Bosch-Príncep R, Salvadó-Usach MT. CD20-negative DLBCL transformation after rituximab treatment in follicular lymphoma: a new case report and review of the literature. Ann Hematol. 2003; 82: 585-588. 10.1007/s00277-003-0694-1

[42]

42 Huang Y, Hu S, Larson DP et al. Composite classic Hodgkin lymphoma and follicular lymphoma: a clinicopathologic study of 22 cases with review of 27 additional cases in the literature. Am J Surg Pathol. 2022; 46: 793-800. 10.1097/pas.0000000000001828

[43]

43 Nomoto J, Hiramoto N, Kato M et al. Deletion of the TNFAIP3/A20 gene detected by FICTION analysis in classical Hodgkin lymphoma. BMC Cancer. 2012; 12: 457. 10.1186/1471-2407-12-457

[44]

44 Yoshida M, Ichikawa A, Miyoshi H et al. High frequency of t(14;18) in Hodgkin’s lymphoma associated with follicular lymphoma. Pathol Int. 2012; 62: 518-524. 10.1111/j.1440-1827.2012.02835.x

[45]

45 Bischin AM, Dorer R, Aboulafia DM. Transformation of follicular lymphoma to a high-grade B-cell lymphoma with MYC and BCL2 translocations and overlapping features of Burkitt lymphoma and acute lymphoblastic leukemia: a case report and literature review. Clin Med Insights Blood Disord. 2017; 10: 1179545X1769254. 10.1177/1179545x17692544

[46]

46 Ok CY, Medeiros LJ, Thakral B et al. High-grade B-cell lymphomas with TdT expression: a diagnostic and classification dilemma. Mod Pathol. 2019; 32: 48-58. 10.1038/s41379-018-0112-9

[47]

47 Chen W, Lau SK, Fong D et al. High frequency of clonal immunoglobulin receptor gene rearrangements in sporadic histiocytic/dendritic cell sarcomas. Am J Surg Pathol. 2009; 33: 863-873. 10.1097/pas.0b013e31819287b8

[48]

48 Laurent C, Syrykh C, Hamon M et al. Resistance of B-cell lymphomas to CAR T-cell therapy is associated with genomic tumor changes which can result in transdifferentiation. Am J Surg Pathol. 2022; 46: 742-753. 10.1097/pas.0000000000001834

Metrics

8

Citations

48

References

Details

Published: Jan 01, 2023
Vol/Issue: 63(1)
Pages: 12-18

Authors

A

Akiko Miyagi Maeshima

Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan

Cite This Article

Akiko Miyagi Maeshima (2023). Histologic transformation of follicular lymphoma: pathologists’ viewpoint. Journal of Clinical and Experimental Hematopathology, 63(1), 12-18. https://doi.org/10.3960/jslrt.22046

Histologic transformation of follicular lymphoma: pathologists’ viewpoint

You May Also Like